Aptamers Engineered Nanocarriers for Cancer Therapy details the selection technologies, biological characteristics, and clinical uses of aptamer-based nano agents for cancer therapeutics. The book helps facilitate speedy solutions for some of the problems pertaining to the manufacture of nano-aptamers – such as toxicity, thermal stability, cost efficiency, tumor penetration and blood stability. Key chapters cover cell-SELEX technology for aptamer selection, mechanisms of multi-drug resistance of cancer, the relevance of aptamers as anticancer therapies, as well as the broad range of aptamer-functionalized nanostructures available. This book provides exciting insights into this relatively new approach to cancer therapeutics, and will be of interest to materials scientists, biomedical engineers, molecular biologists, biochemists and clinical scientists, with a focus on cancer therapy. – Reviews the mechanisms behind multi-drug resistance (MDR) in cancer and how aptamer-mediated novel therapeutic agents and strategies can facilitate MDR reversal- Covers a range of aptamers engineered nanostructures, including PLGA nanoparticles, silica nanoparticles, quantum dots, nucleic acid aptamers, and more- Discusses the challenges associated with using aptamers as cancer therapeutics and how this translates into clinical use
Prashant Kesharwani
Aptamers Engineered Nanocarriers for Cancer Therapy [EPUB ebook]
Aptamers Engineered Nanocarriers for Cancer Therapy [EPUB ebook]
Bu e-kitabı satın alın ve 1 tane daha ÜCRETSİZ kazanın!
Dil İngilizce ● Biçim EPUB ● ISBN 9780323855761 ● Editör Prashant Kesharwani ● Yayımcı Elsevier Science ● Yayınlanan 2022 ● İndirilebilir 3 kez ● Döviz EUR ● Kimlik 8650084 ● Kopya koruma Adobe DRM
DRM özellikli bir e-kitap okuyucu gerektirir